immunity News and Research

RSS

Study shows the strategies tumor cells use to evade immune defense

Scientists are increasingly trying to use the body's own immune system to fight cancer. A new study by the University of Bonn and research institutions in Australia and Switzerland now shows the strategies tumor cells use to evade this attack.

5 Aug 2020

Study: Inhibition of TLK protein stimulates the innate immune system

Tousled-like kinases (TLKs) are a potential therapeutic target for cancer treatment due to their central role in DNA repair and replication.

5 Aug 2020

Laboratory test shows only 60% of COVID-19 patients develop protective antibodies

A laboratory test that has now been developed by a study group from MedUni Vienna is able to determine whether COVID-19 patients develop protective antibodies after having the disease.

5 Aug 2020

Potential antibody treatment for yellow fever developed in 7 months using Rapid Response Strategy

Yellow fever, an acute viral hemorrhagic disease transmitted by infected mosquitoes, infects about 200,000 people and causes an estimated 30,000 deaths each year.

5 Aug 2020

Four-compartment model for COVID-19 can help determine optimal disease suppression strategy

Researchers in China identified four key population categories useful in guiding COVID-19 public health policies aimed at minimizing the spread of the disease and reducing fatalities.

4 Aug 2020

Researchers discover treatment for severe auto inflammatory syndrome

Researchers from the Icahn School of Medicine used a novel genetic sequencing technology to identify the genetic cause of--and a treatment for--a previously unknown severe auto inflam-matory syndrome affecting an 18-year-old girl since infancy.

4 Aug 2020

Dietary choices improve health and immunity amid the global pandemic

In the midst of a global pandemic, eating well in a sustainable way is more important now than ever, Flinders University experts say.

4 Aug 2020

Illustrating the dystopic nature of people’s approach to COVID-19

Are we "Waiting for Godot"- A Metaphor for Covid-19 "Waiting for Godot", one of the greatest works of the Theater of the Absurd is used to illustrate the dystopic nature of our approach to COVID-19.

4 Aug 2020

How COVID-19 lockdown affected the heart

A new study published on the preprint server medRxiv in August 2020 shows that heart rate variability assessments, used to evaluate the health of the heart and blood vessels, are useful in identifying changes in health and well being throughout lockdown related to COVID-19.

4 Aug 2020

Five alternative methods of SARS-CoV-2 suppression

The current pandemic has proved to be challenging to control without stringent and comprehensive non-pharmacological interventions (NPIs), relying mostly on isolation and contact tracing of cases, along with social distancing. However, strategies like these have a huge human cost in terms of restriction of social interactions, resulting in depressive tendencies, disruption of economic activity, and loss of educational resources.

3 Aug 2020

Zika virus mutation responsible for quick spread, birth defects uncovered

A multidisciplinary team from The University of Texas Medical Branch at Galveston has uncovered a Zika virus mutation that may be responsible for the explosive viral transmission in 2015/2016 and for the cause of microcephaly (babies with small heads) born to infected pregnant women.

3 Aug 2020

A new platform to provide information on SARS-CoV-2 immunity or seroprevalence

Who has overcome an infection with the virus without noticing, and how many people have already produced protective antibodies against the new coronavirus? Various antibody studies are now under way that will provide information on immunity or seroprevalence in the population.

3 Aug 2020

Study uncovers how schistosome worms trick the host's immune system

Researchers uncovered in a new study how schistosomes, parasitic flatworms that infect more than 200 million people in the tropics, trick the host's immune system and continue producing eggs for decades.

3 Aug 2020

New biomarkers may identify Type 1 diabetes patients who could benefit from immunotherapy

Scientists at UCL have discovered new biomarkers, which may identify those people with Type 1 diabetes who would benefit from the immunotherapy drug Abatacept, a finding which could eventually help thousands manage the disease more effectively.

3 Aug 2020

Study shows high SARS-CoV-2 seroprevalence, but low death rate in Malawi's health care workers

A study by researchers from Malawi and United Kingdom reveals a significant discrepancy between predicted coronavirus disease (COVID-19) mortality in the observed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence rates in health care workers and reported deaths in urban Malawi in southeastern Africa, indicating early exposure, but a slow progression of the outbreak. Their findings are currently available on the medRxiv preprint server.

3 Aug 2020

Stabilized prefusion spike vaccine candidate induces powerful immune response

A new research paper by scientists at Janssen Vaccines & Prevention BV, in the Netherlands and published on the preprint server bioRxiv* is based on the assumption that an effective vaccine against these infections will induce neutralizing antibodies and an immune response favoring Th1 immunity.

3 Aug 2020

School children unlikely to play a significant role in COVID-19 spread, says Finnish study

A study conducted by researchers in Finland suggests that children who are exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in schools are unlikely to transmit the virus further and play any significant role in the spread of coronavirus disease 2019 (COVID-19).

2 Aug 2020

New bivalent vaccine delivers robust cell-mediated and humoral immunity against SARS-CoV-2

In a groundbreaking bioRxiv study, US researchers demonstrate the capability of next-generation bivalent human adenovirus serotype 5 (hAd5) vaccine for inducing both cellular and humoral immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – using both an S protein sequence optimized for cell surface expression and a conserved nucleocapsid antigen designed to be transported to the endosomal subcellular compartment.

2 Aug 2020

FDA authorizes first two COVID-19 serology tests

Today, the U.S. Food and Drug Administration authorized the first two COVID-19 serology tests that display an estimated quantity of antibodies present in the individual's blood.

1 Aug 2020

Meta-analysis shows 57% mortality reduction with convalescent plasma in COVID-19

Now, a new study published on the preprint server medRxiv in July 2020 reports that an older treatment modality, namely, the use of convalescent antibody-rich plasma, brings down the mortality rate in hospitalized COVID-19 patients by an astonishing 57%. This adds evidence for the use of convalescent plasma in the treatment of high-risk patients.

1 Aug 2020

immunity News and Research

Study shows the strategies tumor cells use to evade immune defense

Study: Inhibition of TLK protein stimulates the innate immune system

Laboratory test shows only 60% of COVID-19 patients develop protective antibodies

Potential antibody treatment for yellow fever developed in 7 months using Rapid Response Strategy

Four-compartment model for COVID-19 can help determine optimal disease suppression strategy

Researchers discover treatment for severe auto inflammatory syndrome

Dietary choices improve health and immunity amid the global pandemic

Illustrating the dystopic nature of people’s approach to COVID-19

How COVID-19 lockdown affected the heart

Five alternative methods of SARS-CoV-2 suppression

Zika virus mutation responsible for quick spread, birth defects uncovered

A new platform to provide information on SARS-CoV-2 immunity or seroprevalence

Study uncovers how schistosome worms trick the host's immune system

New biomarkers may identify Type 1 diabetes patients who could benefit from immunotherapy

Study shows high SARS-CoV-2 seroprevalence, but low death rate in Malawi's health care workers

Stabilized prefusion spike vaccine candidate induces powerful immune response

School children unlikely to play a significant role in COVID-19 spread, says Finnish study

New bivalent vaccine delivers robust cell-mediated and humoral immunity against SARS-CoV-2

FDA authorizes first two COVID-19 serology tests

Meta-analysis shows 57% mortality reduction with convalescent plasma in COVID-19

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News